https://www.selleckchem.com/products/sulfopin.html
Discrepancies exist between international bodies for the diagnosis of impaired fasting glucose (IFG). The aim of this study was to establish the IFG characteristics and evaluate the best diagnostic IFG criteria in a high risk dysglycaemic population. An IFG population ( = 451) was identified from a national representative cross-sectional survey using a fasting blood glucose (FBG) ranging from 5.60 to 6.99mmol/L. These participants were invited for a follow-up oral glucose tolerance test (OGTT). Both FBG results (health survey OG